Crescent Biopharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
300 5th Ave, Waltham, Massachusetts, 024...Phone Number
(617) 430-5595Website
www.crescentbiopharma.comRevenue
$11.9 MillionStock Symbol
CBIOIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Crescent Biopharma
Crescent Biopharma is a biotech company focused on developing precision-engineered treatments for solid tumors, with three promising programs designed to bring effective therapies to market quickly.Explore more
Crescent Biopharma Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Crescent Biopharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Crescent Biopharma had a recent Job posting/layoffs
Check out if Crescent Biopharma is spiking on competitors!
Product Launch: Get notified when Crescent Biopharma launches new products
Congratulate Masked Content for being promoted to Masked Content at Crescent Biopharma
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Crescent Biopharma has new funding data
Crescent Biopharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Crescent Biopharma has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Crescent Biopharma recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Crescent Biopharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Crescent Biopharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Crescent Biopharma.
Crescent Biopharma Tech Stack
A closer look at the technologies used by Crescent Biopharma
See more technologies
Most Recent Scoops
Person-Based
Open Position
Open Position
Open Position
Open Position
Crescent Biopharma News & Media
Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Enrollment progressing in ASCEND Phase 1/2 global clinical trial evaluating CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types in first-line and previously treated patientsCrescent Biopharma Announces Grants of Inducement Awards
WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that the independent Compensation Committee of its Board of Directors approved the grant of options to purchase an aggregate of 52,500 shares of the Company’s ordinary shares to two non-executive employees as equity inducement awards under the CCrescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
WALTHAM, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced that it has closed its previously announced underwritten public offering of 9,387,896 ordinary shares, including 1,293,103 ordinary shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, and in lieCrescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants
WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced the pricing of its underwritten public offering of 8,094,793 ordinary shares and in lieu of ordinary shares to certain investors, pre-funded warrants to purchase up to 525,897 ordinary shares. The ordinary shares are being sold to the public at
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Crescent Biopharma
Sign Up For FreeTo access detailed company insights
Crescent Biopharma is a biotech company focused on developing precision-engineered treatments for solid tumors, with three promising programs designed to bring effective therapies to market quickly.... Read More
